In April of 2002, Japanese pharmaceutical company Daiichi Sankyo received approval from the United States Food and Drug Administration (FDA) to launch its new product in the United States. The product, Benicar, is a prescription medication used to treat hypertension, or lower someone’s blood pressure. Daiichi Sankyo went on to spend over $1 billion in advertising for the drug, promoting its effectiveness and safe use. In 2012, the FDA estimated that approximately 10.4 million prescriptions were prescribed to patients with blood pressure problems. However, it has recently been discovered that Benicar can cause serious gastrointestinal problems to those who use the drug.
BENICAR AND SPRUE-LIKE ENTEROPATHY
From 2008 to 2011, the Mayo Clinic in Rochester, Minnesota studied patients who had been hospitalized with symptoms similar to that of celiac disease – chronic diarrhea, weight loss, and enteropathy. However, unlike people who suffer from celiac disease, the patients being studied were unable to curb any of their symptoms when they switched to a gluten-free diet. Also, the blood tests taken did not show a diagnosis of celiac disease either. When the Mayo Clinic researchers discovered the fact the all the patients they were studying were prescribed Benicar, they ordered them to stop taking the medication.
What they found when the patients stopped taking the drugs was their symptoms disappeared as well. These findings led them to studying 40 more patients who were found to have sprue-like enteropathy from taking Benicar. Once patients stopped taking the hypertension medicine, all gastro-intestinal problems, from diarrhea, vomiting, stomach pain, and intestinal inflammation stopped, and patients regained an average of 27 lbs.
In the wake of these study results, in July of 2013, the FDA required the drug manufacturer to place GI warning label on Benicar, notifying the consumer of the risk of sprue-like enteropathy. The symptoms from sprue-like enteropathy can develop anywhere from a few months to a few years after starting treatment with Benicar. The drug has been marketed as Benicar, Benicar HCT, Azor, Tribenzor, and olmersartan.
CONTACT CLEARWATER DEFECTIVE DRUG LAWYERS DOLMAN LAW GROUP
The severe side effects and their symptoms that can result from taking Benicar can have serious damaging effects on the person using them. It is possible for you to be hospitalized, resulting in lost wages, and suffer from extreme weight loss, making you become weak and unable to perform the tasks that you could once do with ease.
Our experienced defective drug attorneys at Sibley Dolman Gipe Accident Injury Lawyers, PA are currently investigating claims from users of Benicar who have experienced the following symptoms: severe diarrhea, weight loss, vomiting, and constant nausea.
If you, a loved one, or someone you know has suffered from any of the previously listed symptoms, or has been misdiagnosed with celiac disease due to the use of the prescription drug Benicar, you may be entitled to compensation. The attorneys at Sibley Dolman Gipe Accident Injury Lawyers, PA will work diligently to make sure you receive the compensation you deserve and that those who were negligent are held responsible. Call (833) 606-DRUG  or contact us via our online contact form today for a free and confidential consultation on your Benicar case.